Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Immusoft
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
May 06, 2026
From
Immusoft
Via
GlobeNewswire
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
March 30, 2026
From
Immusoft
Via
GlobeNewswire
Immusoft Acquires Exclusive, Worldwide Rights to Intellectual Property for Genome Edited Primary B Cells from the University of Minnesota
March 27, 2023
From
Immusoft
Via
Business Wire
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
January 27, 2023
From
Immusoft
Via
Business Wire
Immusoft and Takeda Collaborate to Discover and Develop Cell Therapies for Rare Neurometabolic Disorders
October 13, 2021
From
Immusoft
Via
Business Wire
Immusoft Announces Formation of Scientific Advisory Board
June 23, 2021
From
Immusoft
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.